Peter Navarro: “The heavy focus is on the generics. The problem we have with…”

“Okay, what else you got? Yes, sir. Generic pharmaceutical drugs and the patented or new high end drugs. The heavy. Good question. The heavy focus is on the generics. The problem we have with generics is that they have very, very low margins. to make money on. So we tend dramatically to under produce them here. Whereas the patented ones, they have big margins and therefore more room to run here in the United States.” (08:33–08:49)

This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.